CHU Besançon
CHU Besançon
Besançon, France32 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT03616886 | |
| Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-09-30 | NCT06918002 | |
| De-escalation Study for Stage IIa/IIb < 3 cm Seminoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, germinoma, neoplasm, seminoma | Recruiting | Phase 2 | 2026-09-15 | NCT05529251 | |
| Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms | Aneurysm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-09-02 | NCT06689410 | |
| Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial | autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease | Recruiting | Phase 3 | 2026-08-31 | NCT05545384 | |
| Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 2 | 2026-08-28 | NCT06529718 | |
| Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Phase 3 | 2026-07-01 | NCT07638553 | |
| Effect of the IBAIP in Preterm Infants Neurodevelopment | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not applicable | 2026-06-26 | NCT04685356 | |
| Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome | Death, Death, Sudden, Infant Death, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sudden Infant Death | Recruiting | Not stated | 2026-06-18 | NCT06244433 | |
| Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis | Digestive System Diseases, Infections, Intraabdominal Infections, Peritoneal Diseases, peritonitis | Recruiting | Not applicable | 2026-06-08 | NCT04604730 | |
| The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-06-08 | NCT04405583 | |
| French National Database of Rare Dermatological Cancers | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epidermal appendage tumor, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, viral infectious disease | Recruiting | Not stated | 2026-05-22 | NCT03210935 | |
| Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-05-20 | NCT07205731 | |
| LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-05-08 | NCT04768322 | |
| the REMONO-CD and the REMONO-UC Studies | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Enrolling by invitation | Not stated | 2026-05-04 | NCT07564609 | |
| Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes | mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-05-01 | NCT07087353 | |
| Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years | Bone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 2 | 2026-04-28 | NCT06646497 | |
| Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor | graft versus host disease | Recruiting | Phase 3 | 2026-04-27 | NCT06083129 | |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy | pancreatic adenocarcinoma | Not yet recruiting | Not applicable | 2026-04-23 | NCT07547033 | |
| Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, digestive system disorder, esophageal atresia, esophageal disorder | Recruiting | Not stated | 2026-04-22 | NCT05995171 | |
| Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults | childhood malignant neoplasm, neoplasm | Recruiting | Not stated | 2026-03-31 | NCT04477681 | |
| Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | human papillomavirus-related penile squamous cell carcinoma, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT03260023 | |
| Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-01-30 | NCT05917405 | |
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy | Urothelial Bladder Cancer | Recruiting | Phase 2 | 2025-11-18 | NCT04428554 | |
| LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) | B-cell neoplasm, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system cancer, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-09-25 | NCT04446962 |